Respiratory failure

• 1. Introduction

  ›

  Respiratory failure begins with a quiet arithmetic failure inside the blood. The arterial oxygen, the carbon dioxide, or both can no longer be held at normal levels. The reference targets are precise. Oxygen partial pressure should sit above 80 mmHg, which is 11 kPa. Carbon dioxide should stay below 45 mmHg, or 6.0 kPa. When those numbers drift, the body has a name for each direction of failure. A fall in the oxygen carried in the blood is hypoxemia. A rise in arterial carbon dioxide is hypercapnia. The brain feels it first, because ischemia there can alter a person's state of consciousness. So what makes the same organ system fail in such different ways, and why do clinicians sort that failure into numbered types? The answers run from the airway to the blood supply to the lung tissue itself, and finally to a sobering survival statistic.

• 2. Type One

  ›

  PaO2 below 60 mmHg, with carbon dioxide normal or low, defines Type 1 respiratory failure. The core problem is oxygenation. PaO2 is decreased, PaCO2 stays normal or even drops below 50 mmHg, and the alveolar-arterial oxygen gradient, the PA-aO2, widens. The causes all attack the path oxygen takes into the blood. Low ambient oxygen, such as at high altitude, is one. Ventilation-perfusion mismatch is another, where parts of the lung receive air but not enough blood to absorb it, as in pulmonary embolism or acute respiratory distress syndrome. Alveolar hypoventilation from reduced respiratory muscle activity can do it too, and if severe enough that same mechanism tips into Type 2. A diffusion problem keeps oxygen from crossing into the capillaries because of parenchymal disease, as in pneumonia. A right-to-left shunt mixes oxygenated blood with non-oxygenated venous blood, seen in arteriovenous malformation, complete atelectasis, severe pneumonia, or severe pulmonary edema. Each mechanism leaves the carbon dioxide largely alone, which is exactly what separates this type from the next.

• 3. Type Two

  ›

  Hypercapnia is the signature of Type 2 respiratory failure, with PaCO2 climbing above 50 mmHg and the blood turning acidic, pH falling below 7.35. Here the oxygen may be low or normal, but the alveolar-arterial gradient stays normal, because the lungs are not the bottleneck. The body still generates carbon dioxide. It simply cannot eliminate it. The root cause is inadequate alveolar ventilation, and the conditions that produce it cluster into recognizable groups. Increased airways resistance appears in chronic obstructive pulmonary disease, asthma, and suffocation. Reduced breathing effort follows drug effects, a brain stem lesion, or extreme obesity. A shrinking area of lung available for gas exchange shows up in chronic bronchitis. Neuromuscular problems like Guillain-Barre syndrome and motor neuron disease weaken the bellows. So can a chest that is deformed by kyphoscoliosis, made rigid by ankylosing spondylitis, or broken into a flail segment. Treatment leans on non-invasive ventilation, a tool whose role grows clearer once the rarer types are accounted for.

• 4. The Rarer Types

  ›

  Surgery created the case for a third category. Type 3 respiratory failure is mechanically a Type 1, with low PaO2 and normal or low PaCO2, but it earned its own label because of how often it appears around operations. It is also called perioperative respiratory failure. Its central mechanism is atelectasis, the collapse of the functional lung units that carry out gas exchange. After general anesthesia, functional residual capacity drops, and dependent lung units collapse. Type 4 begins not in the lung but in the body's demand. It occurs when metabolic oxygen demands exceed what the cardiopulmonary system can supply. It often stems from hypoperfusion of the respiratory muscles in patients in shock, including cardiogenic shock and hypovolemic shock. Those patients frequently suffer respiratory distress from pulmonary edema, as in cardiogenic shock. Lactic acidosis and anemia can drive Type 4 as well. Yet for all four numbers, Types 1 and 2 remain the most widely accepted framing.

• 5. Reading The Body

  ›

  Clubbing of the fingertips is one of the visible clues that a body is starving for oxygen. The physical exam in respiratory failure gathers signs of impaired oxygenation. Accessory muscle use during breathing signals respiratory distress. Altered mental status appears as confusion or lethargy. Peripheral cyanosis tints the mucosal membranes, fingers, or toes a bluish color, while the conjunctiva turns pale and the breathing rate quickens into tachypnea. The body also broadcasts the cause beneath the failure. When cardiogenic shock is the source, with perfusion dropping because the heart is failing, signs of heart dysfunction such as pitting edema appear alongside the breathing trouble. Those clues point the way toward the test that confirms what the eyes suspect.

• 6. Confirming The Diagnosis

  ›

  Arterial blood gas assessment is the gold standard for diagnosing respiratory failure. It measures blood oxygen levels, the PaO2, and every type of respiratory failure carries a low blood oxygen level, so the ABG cuts straight to the defining feature. Capnometry adds a second reading by measuring carbon dioxide in exhaled air. Pulse oximetry tracks the fraction of hemoglobin saturated with oxygen, reported as SpO2. Imaging completes the picture rather than making the call. Ultrasonography and radiography assist the diagnostic workup, often by pinning down the etiology behind a person's respiratory failure. Naming that underlying cause matters, because treatment turns on it.

• 7. Treatment And Odds

  ›

  Naloxone reverses respiratory failure caused by an opioid overdose, a clean antidote for a specific poison. Most benzodiazepine overdoses, by contrast, do not benefit from flumazenil. Treating the underlying cause comes first whenever possible. When intubation is not indicated, high-flow nasal oxygen is the first-line treatment for acute hypoxic respiratory therapy. The medication list runs by cause: bronchodilators for airways disease, antibiotics for infections, glucocorticoids for numerous causes, and diuretics for pulmonary edema. Type 1 failure may need oxygen therapy to reach adequate saturation, and when oxygen alone fails, options escalate to heated humidified high-flow therapy, continuous positive airway pressure, or endotracheal intubation with mechanical ventilation. Type 2 often calls for non-invasive ventilation, with mechanical ventilation held in reserve if NIV fails; respiratory stimulants such as doxapram are now rarely used. Even before the hospital, starting continuous positive airway pressure shows tentative benefit. The stakes are stark. Of every three hospitalized cases of acute respiratory failure, one ends in death.